07:57 AM EST, 02/25/2025 (MT Newswires) -- Harmony Biosciences ( HRMY ) reported Q4 adjusted earnings Tuesday of $1.08 per diluted share, compared with $0.73 a year earlier.

Analysts surveyed by FactSet expected $0.88.

Net product revenue for the quarter ended Dec. 31 was $201.3 million, compared with $168.4 million a year earlier. Analysts surveyed by FactSet expected $201 million.

The company said it expects net product revenue of $820 million to $860 million for 2025. Analysts surveyed by FactSet expect $844.4 million.